This week, I’m taking a break from the latest independent pharmacy news to share some great news about how TRxADE will be able to help you even more moving forward. Some of these items are in the planning stage, while others are already in place. And the very first item is that we want to […]
This author has yet to write their bio.Meanwhile lets just say that we are proud Admin contributed a whooping 17 entries.
Entries by Admin
Two complementary bills introduced the same day On January 29th, bills were introduced in both the U.S. Senate and House of Representatives to “provide for coverage under the Medicare program of pharmacist services.” If passed and signed into law, patients in underserved areas would have access to Medication Therapy Management from pharmacists who would receive […]
While many in the public and private sectors proclaim their passion for reshaping our healthcare system to be more efficient, less expensive, and provide better outcomes, it often seems that the “innovations” introduced leave independent pharmacies holding the bag – or, to be more precise, paying the bill – while patients suffer the consequences.
Balancing the benefits of drug rebates vs. low wholesale drug prices can be a challenge for independent pharmacies. Since there are no clearly defined best practices to follow, each pharmacy must create its own. To help you formulate your pharmacy’s practices, I will lay out the pros, cons, and question marks of each.
Follow us on Facebook
- What's New Related to Drugs May 20, 2022Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.FDA
- Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis May 20, 2022Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis zbecker Fri, 05/20/2022 - 15:45zbecker
2420 Brunello Trace
Lutz, Florida 33558
9am-5pm Mon-Fri EST
Click Here For Contact Request Form